Medeon Biodesign (Taiwan) Today
| 6499 Stock | TWD 43.20 1.20 2.70% |
Performance0 of 100
| Odds Of DistressOver 67
|
Medeon Biodesign is selling for under 43.20 as of the 24th of November 2024; that is 2.7% down since the beginning of the trading day. The stock's lowest day price was 43.2. Medeon Biodesign has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Medeon Biodesign are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Moving against Medeon Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medeon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medeon Biodesign's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medeon Biodesign or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Medeon Biodesign (6499) is traded on Taiwan OTC Exchange in Taiwan and employs 16 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medeon Biodesign's market, we take the total number of its shares issued and multiply it by Medeon Biodesign's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medeon Biodesign operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 87.64 M outstanding shares.
Medeon Biodesign generates negative cash flow from operations
Check Medeon Biodesign Probability Of Bankruptcy
Ownership AllocationMedeon Biodesign maintains a total of 87.64 Million outstanding shares. Medeon Biodesign holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medeon Ownership Details
Medeon Biodesign Risk Profiles
Although Medeon Biodesign's alpha and beta are two of the key measurements used to evaluate Medeon Biodesign's performance over the market, the standard measures of volatility play an important role as well.
Medeon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medeon Biodesign without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.